Amiodarone-induced pulmonary toxicity (AIPT) is one of the most serious adv
erse effects of amiodarone therapy and can be fatal. Therefore, vigilant mo
nitoring is advised. Baseline chest radiograph and pulmonary function tests
and follow-up chest films at 3-month intervals are advocated. However, sin
ce abnormalities on these two examinations do not always precede symptoms,
patient self-reports of respiratory symptoms appear to be the best method f
or early detection of AIPT.